Pscitech 2016 01 002
Pscitech 2016 01 002
Pscitech 2016 01 002
a r t i c l e i n f o a b s t r a c t
Article history: To be better used as implant materials in bone regeneration, bioactivity and osteogenesis of poly(methyl
Received 3 November 2015 methacrylate) (PMMA)-based bone cement need to be further enhanced. In this study, bioactive hy-
Received in revised form droxyapatite (HA) nanoparticle decorated with polydopamine (pDA) and BMP2 mimicking peptide
30 December 2015
(serine-serine-valine-proline-threonine, SSVPT) was incorporated into PMMA-based cement (px-HA/
Accepted 4 January 2016
PMMA). The presence of pDA layer on HA surface could keep the mechanical property of px-HA/PMMA
Available online 5 January 2016
cements comply with the requirement of clinical application. More importantly, the px-HA/PMMA
cement exhibited excellent biomechanical property with enhanced interfacial adhesion between cement
Keywords:
Poly(methyl methacrylate)
and swine femur. Biomineralization and cell experiment in vitro showed that the incorporation of pDA-
Hydroxyapatite coated HA and SSVPT can synergistically enhance the bioactivity of px-HA/PMMA cement for regener-
Polydopamine ation and provide an attractive strategy to reconstruction of load-bearing bone.
BMP-2 biomimetic peptide © 2016 Elsevier Ltd. All rights reserved.
Bioactivity
http://dx.doi.org/10.1016/j.compscitech.2016.01.002
0266-3538/© 2016 Elsevier Ltd. All rights reserved.
T. Kang et al. / Composites Science and Technology 123 (2016) 232e240 233
as therapeutic proteins that can accelerate ectopic bone formation purchased from Amresco (USA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-
[21]. BMP2 is the most powerful osteogenic factor to promote diphenyltetrazolium bromide (MTT) was purchased from GBCBIO
proliferation, migration, and the differentiation of mesenchymal Technology Inc and used as received.
stem cells (MSCs) into osteoblasts [22e24]. Functional oligopeptide
sequence derived from BMP2, such as serine-serine-valine-proline- 2.2. Surface modification of HA
threonine (SSVPT) has been harnessed to fabricate biomaterials
that can facilitate biomineralization and osteogenesis [25,26]. The surface modification of nano-HA by pDA was carried out
In this study, pDA was polymerized in situ to form covalent according to literature [31]. In detail, DA (33 g) and hydroquinol
coating on the surface of the HA nanoparticles; and to the pDA (0.19 g) were dispersed in 50 mL of ethanol/water (9:1, v/v) mixture
coating was conjugated SSVPT peptide via Michael-type addition at 50 C for one h and the pH was adjusted to 3.5e4.0 before adding
[27]. A bioactive PMMA-based bone cement was fabricated from nano-HA (8 g) under stirring. After 48 h reaction, the reaction
this SSVPT/pDA-coated HA nanoparticles at content as high as mixture was centrifued at 10,000 rpm to isolate the pDA-coated HA
40 wt%; the mechanical properties, biomineralization, and cyto- nanoparticles (d-HA). The solid was resuspended-centrifued in THF
toxicity of this cement were evaluated in detail (Fig. 1). The syn- for three times. And then, the product was dried at 60 C for 48 h
ergistic effect of pDA-coated HA and SSVPT on cell culture was under vacuum.
studied in vitro. To conjugate the BMP-2 mimicking peptide onto the surface of
d-HA, d-HA (0.5 g) was dispersed in 50 mL of distilled water under
sonication for 10 min, to which the BMP-2 mimicking peptide
2. Materials and experimental
(20 mg) in 200 mL of PBS was added. After the reaction was
vigorously stirred at 25 C for 24 h, the mixture was centrifuged and
2.1. Materials
washed using distilled water for three times to remove physically
adsorbed peptide. The final product (p-HA) was dried at 60 C for
Methyl methacrylate (MMA) and poly(ethylene glycol) 2000
48 h under vacuum.
(PEG 2000, Mn 2000 g/mol) were purchased from Damao Chemical
Reagent Factory (Tianjin, China). MMA was used after distillation
2.3. Characterization of HA nanoparticle
under reduced pressure. Poly(vinyl alcohol) (PVA, Mw
30,000e50,000 g/mol) and benzoyl peroxide (BPO) were pur-
The successful conjugation of pDA and SSVPT onto the surface of
chased from Sinopharm Chemical Reagent Co., Ltd. (Shanghai,
HA was validated by Fourier-transformed infrared spectroscopy
China). Dopamine (DA) and dimethyltryptamine (DMT) were pur-
(FT-IR, Bruker, Germany). The HA (0.002 g) was pressed into KBr
chased from Aladdin Reagent Company (Shanghai, China) and used
(0.15 g) pellets at 25 C and scanned for 16 times in the range of
as received without further purification. HA nanoparticles (average
400e4000 cm1.
length 30 nm, diameter 8 nm) [28] and BMP2 mimicking peptide
The morphology of d-HA and p-HA were observed under a
(SSVPT-NH2) [29] were prepared according to the reported proce-
transmission electron microscope (TEM, FEI Tecnai G2 Spirit,
dure with minor modifications. Simulated body fluid (SBF) was
Netherlands) at an acceleration voltage of 80 kV. A droplet of HA
prepared following reported protocol [30]. All other reagents were
suspension was placed on a copper grid and allowed to dry before
of analytical grade and used as received.
the observation.
Human fetal osteoblast (hFOB) was purchased from the cell
The modification degree, i.e. the content, of pDA and SSVPT on
bank of Chinese Academy of Sciences at Shanghai, China. Dubeco's
the surface of HA was measured thermogravimetrically on a TGA/
Modified Eagle's Medium (DMEM) and fetal bovine serum (FBS)
DSC1 instrument (Meteler, USA). In detail, 8 mg of HA, d-HA, and p-
were purchased from Hyclone (USA). Geneticin Selective Antibiotic
HA were heated respectively from 30 C to 700 C with a heating
(G-418 Sulfate) was purchased from Notlas (Beijing, China). N-2-
rate of 10 C/min under nitrogen atmosphere. The weight per-
Hydroxyethylpiperazine-N-ethanesulphonic acid (HEPES) was
centage of pDA coating was calculated by the formula as follows:
where Wo is the weight loss of the sample, and WHA is the mass of
residual nanoparticles at 700 C.
Table 1
Feed capacity of the solid component.
PMMA 1 0 0 0 0 0.04
BaSO4/PMMA 0.56 0.4 0 0 0 0.04
p/PMMA 0.56 0.3 0 0 0.1 0.04
HA/PMMA 0.56 0 0.4 0 0 0.04
d-HA/PMMA 0.56 0 0 0.4 0 0.04
Fig. 1. Schematic illustration of synergistic mechanism of reinforcing bioactivity of
px-HA/PMMA (x ¼ 1) 0.56 0 0 0.3 0.1 0.04
PMMA-based cement with polydopamine-coated hydroxyapatite and BMP2 bio-
px-HA/PMMA (x ¼ 2) 0.56 0 0 0.2 0.2 0.04
mimetic peptide.
234 T. Kang et al. / Composites Science and Technology 123 (2016) 232e240
Fig. 3. (a) FTIR spectra, (b) TGA, and (cee) TEM images of HA nanoparticles.
T. Kang et al. / Composites Science and Technology 123 (2016) 232e240 235
2.8. In vitro cytotoxicity containing 1 mL of growth medium in each well. After incubation
for 24 h (34 C, 5% CO2), the medium was removed. 100 mL of the
The cytotocixity of the bone cements towards hFOB was assayed extract of the bone cement was added to each well. After incubation
using the extracts of the cements in DMEM. The extracts of PMMA- for 24 h, 60 mL of MTT solution (5 mg/mL) in DMEM was added to
based bone cements were prepared according to requirement of each well. After incubation for additional four h, the MTT medium
ISO10993 standard. After being pretreated by 75% ethanol and PBS was removed and 200 mL of DMSO was added to dissolve the for-
for 24 h respectively, the bone cements (diameter thickness: mazan. The optical density of each well was measured at 570 nm on
6 5 mm) were subsequently soaked in DMEM (the ratio of cement a plate reader (BioTek Synergy4, USA). DMEM without extract was
to medium was 1/5 (w/v)) at 34 C for 24 h. The medium was then used as control. The cell viability was calculated by the following
used as the extract (marked as “extract”) in the following cell cul- equation:
ture without further filtration.
hFOBs were seeded into a 48-well plate (5.0 104 cells/well) Cell viability% ¼ (ODcement/ODcontrol) 100 (2)
Fig. 4. (a) Compressive strength, (b) flexural strength, and (c) flexural modulus of PMMA-based bone cement after soaked in PBS for 3 days at 25 C. (deg) SEM image of fracture
surface of PMMA-based bone cement after bending test.
236 T. Kang et al. / Composites Science and Technology 123 (2016) 232e240
where ODcontrol and ODcement were the optical densities of corre- (Fig. 3e) nanoparticles were observed as compared with HA
sponding samples. (Fig. 3c).
filler in the PMMA matrix. The better dispersion of p-HA in the interact with Ca2þ in the mineral of swine femur and strengthen
PMMA cement matrix in turn resulted in moderately improved the interfacial adhesion [16], this might become an innovative
mechanical properties (Fig. 4g). strategy for clinical bone repair.
Although the d-HA aggregates in PMMA matrix and deteriorates
the bulk mechanical properties of the cement, the presence of d-HA
may significantly enhance the interfacial adhesion between fresh 3.3. Biomineralization
swine femur segment and bone cement. The adhesion forces of d-
HA/PMMA, p1-HA/PMMA, and p2-HA/PMMA cement with swine Another key point of bone cement for clinical application is to
femur were 4.5 ± 0.2 MPa, 4.71 ± 0.32 MPa, and 4.72 ± 0.28 MPa induce the formation of apatite [32]. Similar to that on the surface
(Fig. 5), which were much higher than those of HA/PMMA of PMMA cement in our previous report [33], no discernible
(3.5 ± 0.8 MPa) and BaSO4/PMMA (3.3 ± 0.4 MPa) cement. Taking mineralization can be found on the surface of BaSO4/PMMA cement
advantage of the surface-anchored catecholamine moieties in pDA, (Fig. 6, image a1ea3) after 14 days of immersion in SBF. Upon the
it is reasonable to speculate that the pDA moiety in the cement may addition of SSVPT (image b1eb3) or nano-HA particles (image
c1ec3) alone to the PMMA matrix, needle-like crystallite was found
Fig. 6. SEM images of PMMA-based bone cement soaked in SBF solution at 37 C for 0 (a1ef1), 7 (a2ef2), and 14 (a3ef3) days. EDX spectra of the surface of PMMA-based bone cement
after immersion in SBF at 37 C for 14 days (a4ef4). (Scale bar represents 5 mm).
238 T. Kang et al. / Composites Science and Technology 123 (2016) 232e240
to deposit on the surface of cements and the amount of crystallites attachment is one of the key challenge for vertebral repair. The
increased with time, demonstrating that the bioactive SSVPT or HA effect of pDA-coated HA and SSVPT peptide on the bioactivity of
in the PMMA-based bone cement can induce the formation of cement was evaluated in terms of the cell morphology and
mineral [34,35]. In the case of d-HA/PMMA cement, the mineral adherent number on the surface of cements. Our previous study
(image d3) was much thicker than that on HA/PMMA cement (im- [33] had revealed that the introduction of bioactive HA into PMMA-
age c3) after soaking in SBF for 14 days. The much thicker mineral based cement would promote cementecell interaction and induce
layer on d-HA/PMMA cement can be attributed to the abundant deposition of extracellular matrix (ECM) proteins to offer a good
catecholamine moieties in pDA layer that could induce nucleation substrate for cell adhesion [36]. After 3-day incubation, hFOBs
of hydroxyapatite by concentrating Ca2þ at the interface [16]. showed preferential anchorage to the surface of HA/PMMA cement
The introduction of BMP2 biomimetic peptide can further (Fig. 8b) compared with that of BaSO4/PMMA cement (Fig. 8a).
accelerate the formation of mineral. As shown in image e1ee3 Multi-layer cells were observed on the surface of px-HA/PMMA
(Fig. 6), the crystallite layer became increasingly thicker on p1-HA/ cement (Fig. 8c and d) and hFOBs displayed typical polygonal
PMMA surface. Compared with that of d-HA/PMMA cement (image morphology with more prominent filopodia (insets in Fig. 8c and
d1ed3), higher amount of mineral on the surface of p1-HA/PMMA d). The phenomenon revealed that the presence of pDA, HA, and
cement was observed, suggesting that the introduction of SSVPT SSVPT can improve the cement-cells interfacial bioactivity and
could further accelerate the formation of mineral. Additionally, the promote the adhesion of hFOB cell on cement surface [14,37].
7 days' mineralization on the surface of p2-HA/PMMA cement The number of hFOBs on the cements was also quantified
(images f2) was similar to that on surface of p1-HA/PMMA cement (Fig. 8e). In all cases, the number of cells on the cements increased
in 14 days (image e3); after 14 days' mineralization in SBF, the with time, indicating the proliferation of cells on the cements; and
mineral on p2-HA/PMMA cement surface aggregated to form big
blocks (images f3), indicating that increasing the content of SSVPT
peptide could also promote the formation of mineral.
The Ca/P ratio of the newly formed mineral on the surface of
cement was detected by EDX (image a4ef4). After 14 days' miner-
alization, the Ca/P ratio of the minerals decreased gradually from
1.89 to 1.75, approaching that of HA (1.67).
Fig. 8. (aed) SEM images of hFOB cells adhesion on the surface of PMMA-based bone
cement after 3 days' incubation. (e) Relative number of cell adhesion on the surface of
PMMA-based bone cement. (results are the mean ± SD, n ¼ 5, *represents significant
difference between px-HA/PMMA cement (x ¼ 1,2) and the other control cement,
Fig. 7. Cell viability of hFOB cells incubated with the “extract” of PMMA-based bone p < 0.05).
cement. (results are the mean ± SD, n ¼ 5, t-test; *p < 0.05; **P < 0.001).
T. Kang et al. / Composites Science and Technology 123 (2016) 232e240 239
statistic analysis showed that there was significant difference hydroxyapatite containing PMMA bone cement, J. Biomed. Mater. Res. B
Appl. Biomater. 96 (2011) 76e83.
(p < 0.001) between px-HA/PMMA cement (x ¼ 1,2) and the control
[7] K.W. Lye, H. Tideman, J.C. Wolke, M.A. Merkx, F.K. Chin, J.A. Jansen, Biocompa-
groups. After 5 days' culture, there was no statistical difference tibility and bone formation with porous modified PMMA in normal and
between the numbers of cells on the surface of PMMA (black col- irradiated mandibular tissue, Clin. Oral Implants Res. 100 (2013) 100e109.
umn) and BaSO4/PMMA (dark yellow column), suggesting BaSO4 [8] K. Goto, S. Shinzato, S. Fujibayashi, J. Tamura, K. Kawanabe, S. Hasegawa, et al.,
The biocompatibility and osteoconductivity of a cement containing beta-TCP
does not display bioactivity as a filler in the cement. The other for use in vertebroplasty, J. Biomed. Mater. Res. A 78 (2006) 629e637.
groups, such as HA/PMMA, p1-HA/PMMA, and p2-HA/PMMA [9] M.C. Korinth, S. Moersch, C. Ragoss, E. Schopphoff, Biomechanicsl evaluation
showed significantly higher number of cells compared with those of a stand-alone interbody fusion cage based on porous TiO2/glass-ceramic on
the human cervical spine, Biomed. Tech. 48 (2003) 349e355.
of PMMA and BaSO4/PMMA, demonstrating the bioactivity of HA, [10] S. Shinzato, T. Nakamura, T. Kokubo, Y. Kitamura, A new bioactive bone
pDA, and the peptide. For example, the number of cells increased in cement: effect of glass bead filler content on mechanical and biological
the order of HA/PMMA < p1-HA/PMMA < p2-HA/PMMA. The properties, J. Biomed. Mater. Res. 54 (2001) 491e500.
[11] C.M. Madl, M. Mehta, G.N. Duda, Presentation of BMP-2 mimicking peptides in
quantitative results were in accordance with the observations in 3D hydrogels directs cell fate commitment in osteoblasts and mesenchymal
Fig. 8aed. stem cells, Biomacromolecules 15 (2014) 445e455.
It was worth noting that there was a slight increase of cell [12] W.F. Mousa, M. Kobayashi, S. Shinzato, M. Kamimura, M. Neo, S. Yoshihara,
T. Nakamura, Biological and mechanical properties of PMMA-based bioactive
number by adding HA (HA/PMMA compared with BaSO4/PMMA) bone cements, Biomaterials 21 (2000) 2137e2146.
alone or SSVPT (p2-HA/PMMA compared with p1-HA/PMMA) alone. [13] S. Ohba, W. Wang, S. Itoh, Y. Takagi, A. Nagai, K. Yamashita, Acceleration of
Furthermore, in the presence of p-HA/PMMA cement, i.e., upon the new bone formation by an electrically polarized hydroxyapatite
microgranule/platelet-rich plasma composite, Acta Biomater. 8 (2012)
addition of pDA-HA and SSVPT synchronously, a rapid increase in
2778e2787.
cell number of px-HA/PMMA cement was achieved, suggesting a [14] Y.H. Sun, Y. Deng, Z.Y. Ye, S.S. Liang, Z.H. Tang, S.C. Wei, Peptide decorated
possible synergistic effect on cell attachment. In another word, the nano-hydroxyapatite with enhanced bioactivity and osteogenic differentia-
BMP2 mimicking peptide decoration coupled with mussel-inspired tion via polydopamine coating, Colloids Surf. B Biointerface 111 (2013)
107e116.
pDA coating on HA surface can endow PMMA-based cement with [15] L.P. Zhu, J.H. Jiang, B.K. Zhu, Y.Y. Xu, Immobilization of bovine serum albumin
outstanding in vitro bioactivity and cytocompatibility that are onto porous polyethylene membranes using strongly attached polydopamine
potentially beneficial to bone repair and regeneration. as a spacer, Colloids Surf. B Biointerfaces 86 (2011) 111e118.
[16] J. Ryu, S.H. Ku, H. Lee, C.B. Park, Mussel-inspired polydopamine coating as a
universal route to hydroxyapatite crystallization, Adv. Funct. Mater. 20 (2010)
4. Conclusion 2132e2139.
[17] S. Kim, C.B. Park, Mussel-inspired transformation of CaCO3 to bone minerals,
Biomaterials 31 (2010) 6628e6634.
In summary, pDA and SSVPT were simultaneously decorated on [18] C.Y. Chien, T.Y. Liu, W.H. Kuo, M.J. Wang, W.B. Tsai, Dopamine-assisted
the surface of HA by a facile method to enhance the bioactivity of immobilization of hydroxyapatite nanoparticles and RGD peptides to improve
the osteoconductivity of titanium, J. Biomed. Mater. Res. A 101A (2013)
PMMA bone cement. The pDA coating can not only enhance the
740e747.
interfacial adhesion between the cement and host bone tissue, but [19] H.H.K. Xu, J.B. Quinn, Calcium phosphate cement containing resorbable fibers
also provide a wide-range surface for SSVPT conjugation and HA for short-term reinforcement and macroporosity, Biomaterials 23 (2002)
deposition. The combination of pDA-coated HA and SSVPT can 193e202.
[20] S.H. Ku, J. Ryu, S.K. Hong, H. Lee, C.B. Park, General functionalization route for
synergistically accelerate deposition of apatite and promote cell cell adhesion on non-wetting surfaces, Biomaterials 31 (2010) 2535e2541.
attachment on PMMA-based cement. We rationalized that p2-HA/ [21] P.X. Ma, Biomimetic materials for tissue engineering, Adv. Drug Deliv. Rev. 60
PMMA cement here will achieve more desirable cellular response (2008) 184e198.
[22] H.J. Seeherman, K. Azari, S. Bidic, L. Rogers, X.J. Li, J.O. Hollinger, et al., rhBMP-
and bone in-growth as well as ensuring enhanced bone regenera- 2 delivered in a calcium phosphate cement accelerates bridging of critical-
tion efficacy in vertebral repairing. sized defects in rabbit radii, J. Bone Jt. Surg. Am. 88 (2006) 1553e1565.
[23] D.H. Kempen, L. Lu, T.E. Hefferan, L.B. Creemers, A. Maran, K.L. Classic, et al.,
Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery
Acknowledgments vehicles for bone tissue engineering, Biomaterials 29 (2008) 3245e3252.
[24] Y.L. Cai, X.Y. Wang, C.K. Poh, H.C. Tan, M.T. Soe, S. Zhang, et al., Accelerated
bone growth in vitro by the conjugation of BMP2 peptide with hydroxyapatite
This work was supported by Ph.D Programs Foundation of
on titanium alloy, Colloids Surf. B Biointerfaces 116 (2014) 681e686.
Ministry of Education of China (20110171120008), Science and [25] A. Saito, Y. Suzuki, S. Ogata, C. Ohtsuki, M. Tanihara, Activation of osteo-
Technology Program of Guangzhou, China (No. 2014J4100026), progenitor cells by a novel synthetic peptide derived from the bone
Science and Technology Planning Project of Guangdong Province morphogenetic protein-2 knuckle epitope, Biochim. Biophys. Acta 1651
(2003) 60e67.
(No. 2011A060901013), and Guangdong Innovative Research Team [26] Q. Yuan, X.D. Guo, Q.X. Zheng, M. Zhao, Z.Q. Pan, S.G. Chen, et al., Bioinspired
Program(No. 2009010057). growth of hydroxyapatite nanocrystals on PLGA- (PEGASP) n scaffolds
modified with oligopeptide derived from BMP-2, Key Eng. Mater 334e335
(2007) 1261e1264.
References [27] H. Lee, S.M. Dellatore, W.M. Miller, P.B. Messersmith, Mussel-inspired surface
chemistry for multifunctional coatings, Science 318 (2007) 426e430.
pez, E. Unosson, H. Engqvist, C. Persson, Direct and interactive effects of
[1] A. Lo [28] M.Y. Rao, Q.W. Su, Z.Z. Liu, P.Q. Liang, N. Wu, C.Y. Quan, Q. Jiang, Preparation
three variables on properties of PMMA bone cement for vertebral body and characterization of a poly(methyl methacrylate) based composite bone
augmentation, J. Mater. Sci. Mater. Med. 22 (2011) 1599e1606. cement containing poly(acrylate-co-silane) modified hydroxyapatite nano-
[2] M.L. Hernandez, L.M. Alonso, M.M. Pradas, O.E.L. Lozano, D.G. Bello, Com- particles, J. Appl. Poym. Sci. 131 (2014) 40587.
posites of poly(methyl methacrylate) with hybrid fillers (micro/nano- [29] C.Y. Quan, J.X. Chen, H.Y. Wang, C. Li, C. Chang, X.Z. Zhang, Core-shell nano-
hydroxyapatite): mechanical, setting properties, bioactivity and cytotoxicity sized assemblies mediated by the alpha-beta cyclodextrin dimer with a
in vitro, Polym. Compos. 34 (2013) 1927e1937. tumor-triggered targeting property, Acs Nano 4 (2010) 4211e4219.
[3] T. Golz, C.R. Graham, L.C. Busch, J. Wulf, R.J. Winder, Temperature elevation [30] T. Kokubo, H. Takadama, How useful is SBF in predicting in vivo bone
during simulated polymethylmethacrylate (PMMA) cranioplasty in a cadaver bioactivity? Biomaterials 27 (2006) 2907e2915.
model, J. Clin. Neurosci. 17 (2010) 617e622. [31] C.Y. Quan, Z.Z. Liu, M.Y. Rao, Q.W. Su, P.Q. Liang, N. Wu, C. Zhang, Effect of
[4] G. Goncalves, M.T. Portoles, C. Ramirez-Santillan, M. Vallet-Regi, A.P. Serro, modification degree of nano-hydroxyapatite on bioactivity and mechanical
J. Gracio, P.A.A.P. Marques, Evaluation of the in vitro biocompatibility of property of poly(methyl methacrylate)-based bone cement, J. Biomed. Mater.
PMMA/high-load HA/carbon nanostructures bone cement formulations, Res. B 00B (2015), 000e000.
J. Mater. Sci. Mater. Med. 24 (2013) 2787e2796. [32] M. Chen, J.J. Yang, J.Y. Li, K.N. Liang, L.B. He, Z.F. Lin, X.Y. Chen, X.K. Ren, J.S. Li,
[5] G. Goncalves, S.M.A. Cruz, A. Ramalho, J. Gracio, P.A.A.P. Marques, Graphene Modulated regeneration of acid-etched human tooth enamel by a function-
oxide versus functionalized carbon nanotubes as a reinforcing agent in a alized dendrimer that is an analog of amelogenin, Acta Biomater. 10 (2014)
PMMA/HA bone cement, Nanoscale 4 (2012) 2937e2945. 4437e4446.
[6] W.M. Lam, H.B. Pan, M.K. Fong, W.S. Cheung, K.L. Wong, Z.Y. Li, et al., Vitro [33] Z.Z. Liu, Y. Tang, T. Kang, M.Y. Rao, K.J. Li, C.Y. Quan, et al., Synergistic effect of
characterization of low modulus linoleic acid coated strontium-substituted HA and BMP-2 mimicking peptide on the bioactivity of HA/PMMA bone
240 T. Kang et al. / Composites Science and Technology 123 (2016) 232e240
cement, Colloids Surf. B Biointerfaces 131 (2015) 39e46. [36] M.J. Dalby, L. Di Silvio, E.J. Harper, W. Bonfield, Increasing hydroxyapatite
[34] D. Wu, J.J. Yang, J.Y. Li, L. Chen, B. Tang, X.Y. Chen, W. Wu, J.S. Li, Hydroxy- incorporation into poly(methylmethacrylate) cement increases osteoblast
apatite-anchored dendrimer for in situ remineralization of human tooth adhesion and response, Biomaterials 23 (2002) 569e576.
enamel, Biomaterials 34 (2013) 5036e5047. [37] G. Balasundaram, C. Yao, T.J. Webster, TiO2 nanotubes functionalized with
[35] J.Y. Xin, T.C. Chen, Z.F. Lin, P. Dong, H. Tan, J.S. Li, Phosphorylated dendronized regions of bone morphogenetic protein-2 increases osteoblast adhesion,
poly(amido amine)s as protein analogues for directing hydroxylapatite bio- J. Biomed. Mater. Res. A 84A (2008) 447e453.
mineralization, Chem. Commun. 50 (2014) 6491e6493.